FDA OKs Next-Gen Cologuard Test for CRC Screening ...Middle East

Medscape - News
In average-risk adults, Cologuard Plus demonstrated sensitivities of 95% for CRC and 43% for advanced precancerous lesions at 94% specificity in the pivotal BLUE-C trial. Medscape Medical News

Hence then, the article about fda oks next gen cologuard test for crc screening was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Next-Gen Cologuard Test for CRC Screening )

Apple Storegoogle play

Last updated :

Also on site :